Profile data is unavailable for this security.
About the company
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
- Revenue in USD (TTM)11.66m
- Net income in USD-49.15m
- Incorporated2003
- Employees79.00
- LocationBioLine RX LtdModi'in Technology Park2 HaMa'ayan StreetMODIIN 7177871IsraelISR
- Phone+972 86429100
- Fax+972 86429101
- Websitehttps://www.biolinerx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcimedica Inc | 0.00 | -14.94m | 52.46m | 14.00 | -- | 3.04 | -- | -- | -2.64 | -2.64 | 0.00 | 1.61 | 0.00 | -- | -- | 0.00 | -48.34 | -63.99 | -66.59 | -72.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.51 | -- | -44.35 | -- |
Incannex Healthcare Inc | -100.00bn | -100.00bn | 52.70m | -- | -- | 3.73 | -- | -- | -- | -- | -- | 0.8907 | -- | -- | -- | -- | -- | -54.94 | -- | -59.47 | -- | -- | -- | -1,033.07 | -- | -- | 0.00 | -- | 61.92 | 3.38 | -24.35 | -- | 54.12 | -- |
Protara Therapeutics Inc | 0.00 | -42.47m | 52.92m | 26.00 | -- | 0.5031 | -- | -- | -3.74 | -3.74 | 0.00 | 5.11 | 0.00 | -- | -- | 0.00 | -48.67 | -37.02 | -52.23 | -38.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 38.71 | -- | -17.67 | -- |
Aeon Biopharma Inc | 0.00 | -485.01m | 54.38m | 10.00 | -- | -- | -- | -- | -13.04 | -13.04 | 0.00 | -5.20 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -27.67 | -- | -- | -- | -- | -631.85 | -- | -- | -- |
Immix Biopharma Inc | 0.00 | -18.21m | 54.41m | 14.00 | -- | 1.95 | -- | -- | -0.9263 | -0.9263 | 0.00 | 1.06 | 0.00 | -- | -- | 0.00 | -77.50 | -- | -90.46 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.44 | -- | -- | -- |
Anebulo Pharmaceuticals Inc | 0.00 | -9.35m | 54.46m | 2.00 | -- | 10.92 | -- | -- | -0.3633 | -0.3633 | 0.00 | 0.1922 | 0.00 | -- | -- | 0.00 | -91.51 | -- | -104.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.89 | -- | -- | -- |
Mural Oncology PLC | 0.00 | -191.90m | 54.66m | 117.00 | -- | 0.2327 | -- | -- | -11.49 | -11.49 | 0.00 | 13.88 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
America Great Health | 273.71k | -873.02k | 55.09m | 7.00 | -- | -- | -- | 201.28 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.8525 | 0.1674 | 7.71 | 39,101.43 | -273.34 | -543.96 | -- | -- | 92.45 | -247.36 | -320.65 | -1,193.55 | 0.0409 | -1.46 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
Reneo Pharmaceuticals Inc | 0.00 | -70.71m | 55.48m | 8.00 | -- | 0.6829 | -- | -- | -2.17 | -2.17 | 0.00 | 2.43 | 0.00 | -- | -- | 0.00 | -77.06 | -- | -83.08 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -48.95 | -- | -- | -- |
BioLine RX Ltd - ADR | 11.66m | -49.15m | 55.88m | 79.00 | -- | 3.70 | -- | 4.79 | -0.7628 | -0.7628 | 0.1741 | 0.1803 | 0.1939 | -- | 6.40 | 147,531.60 | -81.75 | -52.74 | -127.94 | -65.43 | 55.84 | -- | -421.69 | -3,501.79 | 1.05 | -519.43 | 0.4642 | -- | -- | -- | -142.93 | -- | -50.72 | -- |
Rockwell Medical Inc | 86.62m | -8.42m | 56.08m | 237.00 | -- | 2.65 | -- | 0.6475 | -0.3584 | -0.3584 | 3.33 | 0.6984 | 1.90 | 13.28 | 10.12 | 365,485.20 | -18.47 | -46.29 | -27.53 | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | 1.38 | -3.54 | 0.331 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
Lantern Pharma Inc | 0.00 | -17.53m | 57.77m | 21.00 | -- | 1.62 | -- | -- | -1.62 | -1.62 | 0.00 | 3.32 | 0.00 | -- | -- | 0.00 | -36.82 | -28.83 | -39.63 | -30.17 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.93 | -- | -- | -- |
VolitionRX Ltd | 797.03k | -34.91m | 58.64m | 110.00 | -- | -- | -- | 73.57 | -0.4603 | -0.4603 | 0.0104 | -0.1901 | 0.0425 | -- | 6.32 | 7,245.73 | -188.25 | -111.92 | -- | -196.20 | -- | -- | -4,425.95 | -10,793.31 | -- | -173.85 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
Enzo Biochem Inc | 33.34m | -17.55m | 59.42m | 179.00 | -- | 0.8608 | -- | 1.78 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
Data as of Jun 14 2024. Currency figures normalised to BioLine RX Ltd's reporting currency: US Dollar USD